{"id":110,"date":"2015-05-28T15:56:56","date_gmt":"2015-05-28T06:56:56","guid":{"rendered":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/?page_id=110"},"modified":"2022-02-04T15:34:59","modified_gmt":"2022-02-04T06:34:59","slug":"2008%e5%b9%b4%e5%ba%a6","status":"publish","type":"page","link":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/%e6%a5%ad%e7%b8%be\/2008%e5%b9%b4%e5%ba%a6\/","title":{"rendered":"2008\u5e74"},"content":{"rendered":"<h1>2008\u5e74<\/h1>\n<h1>\u539f\u8457\u8ad6\u6587<\/h1>\n<ul>\n<li>R Kato, Y Hirotani, Y Tsukura, K Urashima, T Yamada, T Kobayashi, T Hayashi, Y Ijiri, K Tanaka. Cross-reactivity between urobilinogen and digoxin; A comparative sensitivity study of FPIA and MEIA-A relationship between urobilinogen and digitalis-like substrances in human urine-. Problemy Terapii Monitorowanej, 19, 3-9, 2008<\/li>\n<li>R Kato, A Fujiwara, T Kawai, J Moriguchi, M Nakagawa, Y Tsukura, Uchida, F Amano, Y Hirotani, Y Ijiri, K Tanaka. Changes in digoxin pharmacokinetics treated with lipopolysaccharide in Wistar rats. Biol. Pharm. Bull. ,31, 1221-1225, 2008.<\/li>\n<li>R Kato, S Yamashita, J Moriguchi, M Nakagawa, Y Tsukura, K Uchida, F Amano, Y Hirotani, Y Ijiri, K Tanaka. Changes of midazolam pharmacokinetics in Wistar rats treated with lipopolysaccharide: relationship between total CYP and CYP3A2 Innate Immun., 14, 291-297, 2008.<\/li>\n<li>R Kato, Y Tokunaga, T Kawai, Y Tsukura, F Amano, Y Hirotani, Y Ijiri, K Tanaka. Effects of CpG-DNA from Escherichia coli on digoxin pharmacokinetics Biol. Pharm. Bull., 31, 1226-1229, 2008<\/li>\n<li>K Ikeda, M Myotoku, Y Hirotani. Characterization of Multidrug Resistance-Associated Protein mRNAs Expression Profiles in Caco-2 and HT-1080 Cell Lines Induced by Methotrexate. Pharmazie, 63(12), 883-889, 2008<\/li>\n<li>Y Hirotani, K Ikeda, R Kato, M Myotoku, T Umeda, Y Ijiri, K Tanaka. Protective Effects of Lactoferrin against Intestinal Mucosal Damage Induced by Lipopolysaccharide in Human intestinal Caco-2 Cells. YAKUGAKU ZASSHI, 128(9), 1363-1368, 2008<\/li>\n<li>Y Hirotani, K Mikajiri, Ikeda, M Myotoku, N Kurokawa. Changes of Peptide YY Levels in the Intestinal Tissue of Rats with Experimental Colitis following Oral Administration of Mesalazine and Prednisolone, YAKUGAKU ZASSHI, 128(9), 1347-1353, 2008<\/li>\n<li>K Ikeda, M Myotoku, N Kurokawa, Y Hirotani. Localization of glucagon-like peptide-2 receptor mRNA expression at different sites in the small intestine of rats. Drug Discov Ther, 2(1), 10-13, 2008<\/li>\n<li>M Myotoku, Y Murayama, A Nakanishi, N Hashimoto, F Koyama, K Irishio, S Kawaguchi, S Yamaguchi, K Ikeda, Y Hirotani. Assessment of Palliative Care Team Activities &#8211; Survey of Medications Prescribed Immediately before and at the Beginning of Opioid Usage -. YAKUGAKU ZASSHI, 128(2), 299-304, 2008<\/li>\n<li>\u6069\u7530\u5149\u5b50, \u897f\u5ddd\u76f4\u6a39, \u8352\u5ddd\u884c\u592b, \u5ee3\u8c37\u82b3\u5f66, \u5c71\u9580\u548c\u660e. DPC\u5305\u62ec\u8a55\u4fa1\u5c0e\u5165\u524d\u5f8c\u306e\u3051\u308b\u5bfe\u8853\u5f8c\u611f\u67d3\u6297\u83cc\u85ac\u4f7f\u7528\u72b6\u6cc1\u306e\u5909\u5316. \u793e\u4f1a\u85ac\u5b66, 27, 29-37, 2008<\/li>\n<li>\u5ee3\u8c37\u82b3\u5f66, \u4e09\u6cb3\u5c3b\u606d\u5b50, \u6c60\u7530\u8ce2\u4e8c, \u540d\u5fb7\u502b\u660e, \u9ed2\u5ddd\u4fe1\u592b. \u4e0b\u75e2\u30e2\u30c7\u30eb\u30e9\u30c3\u30c8\u8178\u7ba1\u7d44\u7e54\u5185\u53ca\u3073\u8840\u6f3f\u4e2dPeptide-YY(PYY)\u306e\u5909\u52d5\u3068\u305d\u306e\u6cbb\u7642\u85acLoperamide\u306e\u5f71\u97ff. YAKUGAKU ZASSHI, 128(9), 1311-1316, 2008<\/li>\n<\/ul>\n<h1>\u5b66\u4f1a\u767a\u8868<\/h1>\n<ul>\n<li>\u540d\u5fb7\u502b\u660e, \u6c60\u7530\u8ce2\u4e8c, \u5ee3\u8c37\u82b3\u5f66. \u7de9\u548c\u533b\u7642\uff08\u7279\u306b\u533b\u7642\u7528\u9ebb\u85ac\uff09\u306b\u95a2\u3059\u308b\u4fdd\u967a\u85ac\u5c40\u52e4\u52d9\u85ac\u5264\u5e2b\u306e\u73fe\u72b6\u53ca\u3073\u610f\u8b58\u306b\u95a2\u3059\u308b\u8abf\u67fb. \u7b2c2\u56de\u65e5\u672c\u7de9\u548c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a, \u6a2a\u6d5c, 2008.10.18\uff5e19<\/li>\n<li>\u6c60\u7530\u8ce2\u4e8c, \u540d\u5fb7\u502b\u660e, \u5ee3\u8c37\u82b3\u5f66. \u80ce\u76e4\u95a2\u9580\u85ac\u7269\u7b49\u4fa1\u306e\u6307\u6a19\u3092\u76ee\u6307\u3057\u305f\u30d2\u30c8\u7d68\u6bdb\u764c\u7d30\u80de\u682aJEG-3\u306e\u5206\u5316\u70ad\u5c64\u819c\u30e2\u30c7\u30eb\u306b\u3088\u308b\u8a55\u4fa1\u7cfb\u306e\u78ba\u7acb. \u7b2c18\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a, \u672d\u5e4c, 2008.9.20\uff5e21<\/li>\n<li>\u540d\u5fb7\u502b\u660e, \u6c60\u7530\u8ce2\u4e8c, \u5ee3\u8c37\u82b3\u5f66. \u5149\u906e\u853d\u578b\u81ea\u52d5\u5fae\u7c92\u5b50\u6e2c\u5b9a\u88c5\u7f6e\u3092\u7528\u3044\u305f\u30d5\u30eb\u30eb\u30d3\u30d7\u30ed\u30d5\u30a7\u30f3\u30a2\u30ad\u30bb\u30c1\u30eb\u6ce8\u3068\u5404\u7a2e\u8f38\u6db2\u88fd\u5264\u3068\u306e\u914d\u5408\u5909\u5316\u306e\u8a55\u4fa1. \u7b2c18\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a, \u672d\u5e4c, 2008.9.20\uff5e21<\/li>\n<li>\u4e0a\u5cf6\u79c0\u6a39, \u521d\u7530\u6cf0\u654f, \u5ddd\u897f\u5712\u4ee3, \u5ee3\u8c37\u82b3\u5f66, \u540d\u5fb7\u502b\u660e, \u6c60\u7530\u8ce2\u4e8c, \u4e2d\u6751\u96c5\u53f8, \u5c0f\u5ddd\u96c5\u53f2. \u65e9\u671f\u4f53\u9a13\u5b66\u7fd2\u306e\u53d6\u308a\u7d44\u307f\u3068\u8a55\u4fa1. \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c128\u5e74\u4f1a, \u6a2a\u6d5c, 2008.3.26\uff5e28<\/li>\n<li>\u5ee3\u8c37\u82b3\u5f66, \u6c60\u7530\u8ce2\u4e8c, \u52a0\u85e4\u9686\u5150, \u540d\u5fb7\u502b\u660e, \u4e95\u5c3b\u597d\u96c4, \u7530\u4e2d\u4e00\u5f66. \u30d2\u30c8\u7d50\u8178\u764c\u7d30\u80de\u7531\u6765Caco-2\u7d30\u80de\u306b\u304a\u3051\u308bLipopolysaccharide(LPS)\u8a98\u767a\u819c\u7c98\u819c\u969c\u5bb3\u306b\u5bfe\u3059\u308bLactoferrin\u306e\u4fdd\u8b77\u4f5c\u7528. \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c128\u5e74\u4f1a, \u6a2a\u6d5c, 2008.3.26\uff5e8<\/li>\n<li>\u6c60\u7530\u8ce2\u4e8c, \u540d\u5fb7\u502b\u660e, \u5ee3\u8c37\u82b3\u5f66. \u30e1\u30c8\u30c8\u30ec\u30ad\u30b5\u30fc\u30c8\u51e6\u7406\u5f8c\u306eCaco-2\u3068HT-1080\u306b\u304a\u3051\u308bMRPs mRNA\u767a\u73fe\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u306e\u5909\u52d5. \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c128\u5e74\u4f1a, \u6a2a\u6d5c, 2008.3.26\uff5e28<\/li>\n<li>\u540d\u5fb7\u502b\u660e, \u6c60\u7530\u8ce2\u4e8c, \u5ee3\u8c37\u82b3\u5f66. \u5149\u906e\u853d\u578b\u81ea\u52d5\u5fae\u7c92\u5b50\u6e2c\u5b9a\u88c5\u7f6e\u3092\u7528\u3044\u305f\u8102\u80aa\u4e73\u5264\u3068\u5404\u7a2e\u8f38\u6db2\u88fd\u5264\u3068\u306e\u914d\u5408\u5909\u5316\u306e\u8a55\u4fa1. \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c128\u5e74\u4f1a, \u6a2a\u6d5c, 2008.3.26\uff5e28<\/li>\n<li>\u5ddd\u897f\u5712\u4ee3, \u521d\u7530\u6cf0\u654f, \u4e0a\u5cf6\u79c0\u6a39, \u6c60\u7530\u8ce2\u4e8c, \u540d\u5fb7\u502b\u660e, \u5ee3\u8c37\u82b3\u5f66, \u4e2d\u6751\u96c5\u53f8, \u5c0f\u5ddd\u96c5\u53f2. \u65e9\u671f\u4f53\u9a13\u5b66\u7fd2\uff08\u75c5\u9662\uff09\u306b\u3088\u308b\u85ac\u5b66\u751f\u306e\u610f\u8b58\u8abf\u67fb. \u7b2c29\u56de\u65e5\u672c\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\u8fd1\u757f\u5b66\u8853\u5927\u4f1a, \u5948\u826f, 2008.2.9\uff5e10<\/li>\n<li><strong><u>\u6c60\u7530\u8ce2\u4e8c<\/u><\/strong>\uff0c\u540d\u5fb7\u502b\u660e\uff0c\u5ee3\u8c37\u82b3\u5f66\uff1a\u80ce\u76e4\u95a2\u9580\u85ac\u7269\u900f\u904e\u306e\u6307\u6a19\u3092\u76ee\u6307\u3057\u305f\u30d2\u30c8\u7d68\u6bdb\u764c\u7d30\u80de\u682aJEG-3\u306e\u5206\u5316\u5358\u5c64\u819c\u30e2\u30c7\u30eb\u306b\u3088\u308b\u8a55\u4fa1\u7cfb\u306e\u78ba\u7acb\u3001\u7b2c18\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a, 2008.<\/li>\n<\/ul>\n<h1>\u8b1b\u6f14\u4f1a<\/h1>\n<ul>\n<li>\u5ee3\u8c37\u82b3\u5f66. \u5f79\u306b\u7acb\u3064\u304a\u85ac\u306e\u8a71. \u89ba\u6c38\u5bfa\u4ecf\u6559\u58ee\u5e74\u4f1a\u5f79\u54e1\u4f1a\u7814\u4fee\u4f1a, <u>2006.8.3<\/u><\/li>\n<li>\u5ee3\u8c37\u82b3\u5f66. \u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u533b\u85ac\u54c1\u3068\u4fdd\u967a\u85ac\u5c40, \u30ec\u30bb\u30d7\u30c8\u30aa\u30f3\u30e9\u30a4\u30f3\u8acb\u6c42\u306b\u95a2\u3059\u308b\u30d6\u30ed\u30c3\u30af\u8aac\u660e\u4f1a, 2008.7.27<\/li>\n<li>\u5ee3\u8c37\u82b3\u5f66. \u304f\u3059\u308a\u306e\u307e\u3068\u3081. \u300c\u306f\u3073\u304d\u306e\u5e02\u6c11\u5927\u5b66\u300d\u8b1b\u5e2b, 2008.7.16<\/li>\n<li>\u5ee3\u8c37\u82b3\u5f66. \u30b5\u30d7\u30ea\u30e1\u30f3\u30c8\u306b\u3064\u3044\u3066. \u300c\u306f\u3073\u304d\u306e\u5e02\u6c11\u5927\u5b66\u300d\u8b1b\u5e2b, 2008.7.2<\/li>\n<li>\u5ee3\u8c37\u82b3\u5f66. \u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u533b\u85ac\u54c1\u306b\u3064\u3044\u3066. \u300c\u306f\u3073\u304d\u306e\u5e02\u6c11\u5927\u5b66\u300d\u8b1b\u5e2b, 2008.6.25<\/li>\n<li>\u5ee3\u8c37\u82b3\u5f66. \u85ac\u5b66\u5171\u7528\u8a66\u9a13OSCE\u5b9f\u969b\u2015\u8a55\u4fa1\u306e\u5b9f\u969b\u306b\u3064\u3044\u3066\u2015. \u8fd1\u757f\u56fd\u7acb\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\u8b1b\u6f14\u4f1a, 2008.6.21<\/li>\n<li>\u5ee3\u8c37\u82b3\u5f66. \u304f\u3059\u308a\u306e\u6982\u8981. \u300c\u306f\u3073\u304d\u306e\u5e02\u6c11\u5927\u5b66\u300d\u8b1b\u5e2b, 2008.5.14<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"2008\u5e74 \u539f\u8457\u8ad6\u6587 R Kato, Y Hirotani, Y Tsukura, K Urashima, T Yamada, T Kobayashi, T Hayashi, Y Ijiri, K Tanaka. Cro &#8230;","protected":false},"author":1,"featured_media":0,"parent":39,"menu_order":28,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/pages\/110"}],"collection":[{"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/comments?post=110"}],"version-history":[{"count":5,"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/pages\/110\/revisions"}],"predecessor-version":[{"id":233,"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/pages\/110\/revisions\/233"}],"up":[{"embeddable":true,"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/pages\/39"}],"wp:attachment":[{"href":"http:\/\/osaka-ohtani-clinpharm.com\/blogWP\/wp-json\/wp\/v2\/media?parent=110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}